Medical Device Marketing Strategy for RFPs and Shortlists
Medical device RFPs are usually decided before they’re written. Procurement committees, value analysis committees, and clinical evaluators research vendors online weeks before a request goes out, and what they find sets the shortlist. Winning the RFP response means winning the digital research phase first: clear positioning, cleared claims, named expertise, and visibility in the places committees actually look, including AI search.
Here’s the thing nobody tells medical device marketers: almost no one searches “how to win a medical device RFP.” We checked. The volume is close to zero. And yet RFP win rates are exactly what keeps device marketing leads up at night.
That’s not a contradiction. It’s a clue. The RFP itself isn’t a marketing moment. By the time a request for proposal lands in your inbox, the shortlist is usually already set. The real marketing event happened earlier and quieter: a procurement analyst, a clinical champion, or a value analysis committee member searched your company name, read three pages, and formed an opinion before you knew you were being evaluated.
If your medical device marketing strategy treats the RFP response as the main event, you’re optimizing the wrong stage of the funnel.
What Actually Decides the Shortlist
Every named committee value analysis committee (VAC), group purchasing organization (GPO) review board, hospital procurement, integrated delivery network (IDN) sourcing team runs some version of the same process. Someone gets asked to vet a category of device. They don’t start with a formal RFP. They start with a search engine, a couple of trade sites, and whatever their clinical or compliance contact already knows.
At that stage, your website is doing the pitch, not your sales team. And it’s doing it to an audience that has almost no patience for vague positioning. A device company that lists generic “innovative solutions” copy next to five competitors saying the same thing gives the committee nothing to differentiate on except price which is the one lever you don’t want to compete on.
The companies that make the shortlist tend to share a pattern: a site that states plainly what the device does, who it’s cleared for, what setting it’s used in, and what changes when a facility adopts it. Not marketing language. Specification-level clarity, written for a reader who is going to be asked to defend the choice to a committee above them.
The Three Readers Who See You Before You Know They’re Looking
This is the part general B2B marketing advice misses, because medical device buying has more people in the room than most categories.
The clinical evaluator wants evidence: outcomes data, peer-reviewed support, how the device performs against what’s currently in use. They’re reading for substance, not tone.
The procurement or VAC reviewer wants comparability: total cost of ownership, training burden, supply reliability, what happens when something breaks. They’re building a case they can defend in a meeting, and your content either gives them that case or forces them to build it from a sales call transcript.
Compliance and legal are checking that nothing on your site oversteps what your clearance actually permits. If your marketing claims run ahead of your regulatory status, that’s not just a legal risk a sharp-eyed reviewer treats it as a trust problem with the whole company, not just the copy.
Three readers, three different questions, one page. That’s the actual brief for a medical device website, and it’s why generic manufacturing marketing templates fall short here even though the underlying discipline B2B, considered purchase, committee decision is the same one Tabula already works in.
Why “Just Do SEO” Doesn’t Work Here and What Does
Standard SEO advice assumes you can say almost anything to rank for it. Medical device marketing doesn’t have that freedom. Claims about efficacy, safety, or comparative performance are constrained by what your clearance or approval actually supports, and that constraint is real, not a copywriting inconvenience to route around.
The fix isn’t to write less. It’s to write differently:
- State what’s cleared, precisely. A specific, accurate claim beats a vague superlative every time a compliance reviewer is reading, and committees read that way by default.
- Lead with named expertise. A page with a credentialed author or a quoted clinical advisor reads as trustworthy in a way anonymous “our team” copy never will. This is the E-E-A-T layer doing real work, not a checkbox — see our breakdown of what E-E-A-T actually means for how that plays out on the page.
- Build comparison content honestly. A page that says plainly who the device suits and who it doesn’t is rare in this category, and it’s exactly the kind of specificity a value analysis committee trusts more than a hedge.
- Treat the site as the first document in the deal file. Assume anything published gets printed and attached to an internal review. Write it that way.
None of this requires bending a regulatory line. It requires being more precise, not less careful.
The Committee Is Already Asking AI About You
Here’s the part that changes month to month right now. Procurement and clinical reviewers increasingly start that early research with an AI tool, not a search box — a ChatGPT or Gemini query about a device category, a comparison, or “who makes X.” What that tool says about you is built from whatever it’s already read about your company. If your site is thin, an AI system fills the gap with whatever else it can find, and that’s rarely flattering and never something you controlled.
This is the same shift we cover in our explainer on GEO, and it applies with extra weight to a regulated category, because the cost of an AI system getting a clinical or compliance detail wrong is higher than in most industries.
Getting ahead of it means making sure your clearest, most accurate answer about your own device exists somewhere AI systems can read it — which is a different, narrower task than ranking in AI search generally, but draws on the same mechanics: clear entity signals, named expertise, and content that states the answer plainly instead of burying it under marketing language.
We’ve also written about how AI Overviews are already reshaping which pages get the click, which is the Google-side version of the same problem.
A Realistic 90-Day Starting Point
We haven’t run this specific playbook for a medical device client yet, so we’ll say that plainly rather than imply otherwise. What follows is how we’d approach the first 90 days for a device manufacturer with no real marketing system in place today, built on the manufacturing marketing work we have proven.
Weeks 1–3 — audit and clearance mapping. Inventory every claim currently live on the site against what your clearance or approval actually permits. Flag anything a compliance reviewer would catch before a competitor’s marketing team does.
Weeks 4–6 — structure the site around the three readers. Rebuild key pages so a clinical evaluator, a procurement reviewer, and compliance can each find their answer without digging. This is unglamorous information architecture work, and it’s the highest-leverage thing on this list.
Weeks 7–10 — build the comparison and specification content. The pages that name what the device suits, what it doesn’t, and how it stacks up on the factors a VAC actually scores against.
Weeks 11–13 — close the entity and trust gaps. Named authors, credentialed contributors, schema that identifies the company clearly to both search engines and AI systems, and a first pass at getting the company’s own facts stated somewhere authoritative and citable.
None of this replaces your regulatory or legal review. It’s a marketing sequence, not a compliance one — run it alongside whoever signs off on claims, not around them.
FAQ
Do medical device companies need different SEO than other B2B manufacturers?
The underlying mechanics are the same — structure, clarity, entity signals, earned trust. What’s different is the claims layer: what you can say has to match your clearance or approval exactly, and that constraint has to be built into the content process from the start, not applied as an edit afterward.
Why doesn’t “medical device RFP strategy” show up as a keyword anywhere?
Because almost nobody searches it. The research happens under different, quieter search behavior — company names, category comparisons, “who makes.” The RFP itself is a downstream event, not a search moment, which is exactly why treating it as the whole strategy misses where the decision actually gets made.
Can AI Overviews or ChatGPT actually influence a medical device procurement decision?
They can shape the first impression a reviewer forms before they ever talk to your sales team, especially when your own site doesn’t clearly state the answer to the question they’re asking. That’s a reason to make sure your most accurate information is easy to find and cite, not a reason to write differently or less carefully.
How do we know if our current marketing agency understands regulated categories?
Ask them how they’d handle a claim they can’t verify against your clearance. If the answer is about tone rather than accuracy, that’s worth knowing before you sign anything. Our piece on what to ask before hiring a marketing agency covers the broader version of this question.
Talk to us about your marketing system.
If you’re a medical device manufacturer trying to get in front of the committees that decide before the RFP is written, we’ll walk you through how we’d approach it — honestly, including where we don’t have direct medtech proof yet.
See how our GEO service works, or get in touch to talk specifics.
Author
Carlos Rios
Carlos Rios is the Founder of Tabula. Before starting the agency, he spent his career inside companies — reporting to leaders who had no patience for vanity metrics and wanted straight answers about what was working and why. He built Tabula around that same standard: a marketing system the client owns, powered by AI and led by experts who explain the plan in plain language. Carlos studied philosophy for six years at York University and holds a Master's in Marketing from the Schulich School of Business.
